CIITA-Exo enhanced the splenocyte proliferation and IL-2 secretion, and induced inflammatory cytokines (such as TNF-α and IL-12) mRNA production, so that CIITA-Exo had a more potent anti-tumor immune response compared to control Exos (168). Here, IL2 is linked to neoplasm.